Cases & Deals

  • Home
  • Practices
  • Abbott launches patent infringement action against Teva

Share

Abbott launches patent infringement action against Teva

April 2007

Client(s) Abbott Laboratories

Jones Day is representing Abbott Laboratories in patent infringement action brought pursuant to the Hatch-Waxman Act and relating to Abbott's patented drug DEPAKOTE®.

Abbott Laboratories v Teva Pharmaceuticals USA, Inc., No. 07 250** (Del.)

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.